1 |
Meghana G, Gowda D, Chidambaram SB, Osmani RA. Amyloid –β pathology in Alzheimer’s disease: A nano delivery approach. Vibrational Spectroscopy 2023;126:103510. [DOI: 10.1016/j.vibspec.2023.103510] [Reference Citation Analysis]
|
2 |
Ailioaie LM, Ailioaie C, Litscher G. Photobiomodulation in Alzheimer’s Disease—A Complementary Method to State-of-the-Art Pharmaceutical Formulations and Nanomedicine? Pharmaceutics 2023;15:916. [DOI: 10.3390/pharmaceutics15030916] [Reference Citation Analysis]
|
3 |
Hua J, Wang F, Wei X, Qin Y, Lian J, Wu J, Ma P, Ma X. A Nanoenzyme Constructed from Manganese and Strandberg-Type Phosphomolybdate with Versatility in Antioxidant and Modulating Conformation of Aβ Protein Misfolding Aggregates In Vitro. Int J Mol Sci 2023;24. [PMID: 36901748 DOI: 10.3390/ijms24054317] [Reference Citation Analysis]
|
4 |
Chakraborty A, Mohapatra SS, Barik S, Roy I, Gupta B, Biswas A. Impact of nanoparticles on amyloid β-induced Alzheimer's disease, tuberculosis, leprosy and cancer: a systematic review. Biosci Rep 2023;43. [PMID: 36630532 DOI: 10.1042/BSR20220324] [Reference Citation Analysis]
|
5 |
Chaurasiya A, Katke S, Panchal K, Nirmal J. Biologics for the management of dementia. Nanomedicine-Based Approaches for the Treatment of Dementia 2023. [DOI: 10.1016/b978-0-12-824331-2.00001-7] [Reference Citation Analysis]
|
6 |
Slekiene N, Snitka V, Bruzaite I, Ramanavicius A. Influence of TiO2 and ZnO Nanoparticles on α-Synuclein and β-Amyloid Aggregation and Formation of Protein Fibrils. Materials 2022;15:7664. [DOI: 10.3390/ma15217664] [Reference Citation Analysis]
|
7 |
Chiang MC, Nicol CJB. GSH-AuNP anti-oxidative stress, ER stress and mitochondrial dysfunction in amyloid-beta peptide-treated human neural stem cells. Free Radic Biol Med 2022:S0891-5849(22)00219-2. [PMID: 35660451 DOI: 10.1016/j.freeradbiomed.2022.05.025] [Reference Citation Analysis]
|
8 |
Lim CL, Raju CS, Mahboob T, Kayesth S, Gupta KK, Jain GK, Dhobi M, Nawaz M, Wilairatana P, de Lourdes Pereira M, Patra JK, Paul AK, Rahmatullah M, Nissapatorn V. Precision and Advanced Nano-Phytopharmaceuticals for Therapeutic Applications. Nanomaterials (Basel) 2022;12:238. [PMID: 35055257 DOI: 10.3390/nano12020238] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
9 |
Md S, Alhakamy NA, Alfaleh MA, Afzal O, Altamimi ASA, Iqubal A, Shaik RA. Mechanisms Involved in Microglial-Interceded Alzheimer's Disease and Nanocarrier-Based Treatment Approaches. J Pers Med 2021;11:1116. [PMID: 34834468 DOI: 10.3390/jpm11111116] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
10 |
Mishra A, Mishra PS, Bandopadhyay R, Khurana N, Angelopoulou E, Paudel YN, Piperi C. Neuroprotective Potential of Chrysin: Mechanistic Insights and Therapeutic Potential for Neurological Disorders. Molecules 2021;26:6456. [PMID: 34770864 DOI: 10.3390/molecules26216456] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|